利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

1151188 条记录 (耗时 0.175 秒)

    HUMAN AUGMENTATION PLATFORM DEVICE AND PHYSICAL ABILITY AUGMENTATION METHOD
    2.
    发明公开
    HUMAN AUGMENTATION PLATFORM DEVICE AND PHYSICAL ABILITY AUGMENTATION METHOD 审中-公开

    公开(公告)号：EP4462231A1

    公开(公告)日：2024-11-13

    申请号：EP22920424.3

    申请日：2022-10-28

    申请人： NTT DOCOMO, INC.

    发明人： ISHIKAWA, Hironori

    IPC分类号： G06F3/01 ,  A61B5/291 ,  A61B5/296 ,  A61F2/54 ,  A61F2/60 ,  A61F2/72 ,  B25J11/00

    摘要： Provided is a human augmentation platform device 100, including: a physical information acquisition unit 110 that acquires physical information indicating a physical ability on a sensing side and a physical ability on a controlled side; a motion data acquisition unit 120 that acquires motion data on the sensing side; a control data generation unit 150 that generates control data on the controlled side on the basis of the physical information acquired by the physical information acquisition unit 110 and the motion data acquired by the motion data acquisition unit 120; and an actuation unit 160 that actuates a body on the controlled side on the basis of the control data. The control data generation unit 150 generates the control data within a range of the physical ability on the controlled side.

    HYDROGEL, AND PREPARATION METHOD AND APPLICATION THEREFOR
    4.
    发明公开
    HYDROGEL, AND PREPARATION METHOD AND APPLICATION THEREFOR 审中-公开

    公开(公告)号：EP4461765A1

    公开(公告)日：2024-11-13

    申请号：EP23803051.4

    申请日：2023-05-12

    申请人： Yan, Yunsong

    发明人： Yan, Yunsong

    IPC分类号： C08J3/075 ,  C08L101/14 ,  A61L27/52

    摘要： Provided in the present invention is a hydrogel. The hydrogel comprises water, glycerol, cellulose ether, and a polymer. The polymer comprises a first polymer and a second polymer. The first polymer is polyacrylonitrile. The second polymer is a cross-linked polyacrylic acid or a cross-linked poly N-hydroxyethyl acrylamide. Further provided are a premix for preparing the hydrogel and a method for preparing the hydrogel. Further provided is a pharmaceutical composition. The pharmaceutical composition can be at least one of a transdermal patch, a wound care patch, a skin care patch and a tissue regeneration patch, and is applied to the fields of medical biology, medical beauty, skin care, etc. Further provided is the application of the hydrogel in preparation of a sensor, an actuator, a transistor, a capacitor, a garment material and a battery. The present hydrogel has better bonding performance, mechanical performance, durability, transparency and air permeability, and also has good drug loading performance and drug sustained-release performance.

    ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING MULTIPLE MYELOMA
    10.
    发明公开
    ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING MULTIPLE MYELOMA 审中-公开

    公开(公告)号：EP4461370A2

    公开(公告)日：2024-11-13

    申请号：EP24191518.0

    申请日：2020-01-08

    申请人： Celgene Corporation

    发明人： WONG, Lilly L.

    IPC分类号： A61P35/00

    摘要： Provided herein are methods of using 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, in combination with a second active agent for treating, preventing or managing multiple myeloma. The second active agent is one or more of a BTK inhibitor, an mTOR inhibitor, a PIM inhibitor, an IGF-1R inhibitor, an MEK inhibitor, an XPO1 inhibitor, a DOT1L inhibitor, an EZH2 inhibitor, a JAK2 inhibitor, a BRD4 inhibitor, a PLK1 inhibitor, an NEK2 inhibitor, an AURKB inhibitor, a BIRCS inhibitor, a BET inhibitor, or a DNA methyltransferase inhibitor.